FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048853732> ?p ?o ?g. }

• W3048853732 endingPage "4858" @default.
• W3048853732 startingPage "4847" @default.
• W3048853732 abstract "Background Invasive lobular breast cancer (BC) is the second most common BC subtype. Prognostic parameters (tumor classification, lymph node status, histologic grade, Oncotype DX recurrence score [RS], progesterone receptor status, and Ki67 index) were retrospectively studied in a large, prospective clinical trial encompassing 2585 patients who had hormone receptor‐positive early BC (the West German Study Group PlanB trial). Methods BCs were centrally reviewed and classified as lobular (n = 353; 14%) or nonlobular (n = 2232; 86%). The median follow‐up was 60 months. Five‐year disease‐free survival (DFS) estimates were obtained using the Kaplan‐Meier method. Prognostic parameters were evaluated using Cox proportional hazard models. Results Lobular BC was associated with higher tumor classification, higher lymph node status, lower histologic grade, lower Ki67 index, and low or intermediate RS. The prevalence of high RS (RS range, 26‐100) was 3‐fold lower in patients who had lobular BC compared with those who had nonlobular BC (8% vs 24%; P < .001). However, 5‐year DFS estimates for lobular and nonlobular BC were similar (92.1% and 92.3%, respectively; P = .673). In multivariate analyses, prognostic parameters for DFS in lobular BC included grade 3 (hazard ratio, 5.06; 95% CI, 1.91‐13.39) and a pathologic lymph node status (pN) of pN3 (hazard ratio, 12.16; 95% CI, 3.87‐38.24), but not RS. By contrast, prognostic parameters in nonlobular BC included grade 3 (hazard ratio, 1.65; 95% CI, 1.11‐2.44), pN3 (hazard ratio, 3.68; 95% CI, 1.60‐8.46), and high RS (hazard ratio, 2.49; 95% CI, 1.69‐3.68). Conclusions Lobular BC is associated with low and intermediate RS, although 5‐year DFS is similar to that of nonlobular BC. The effect of the RS in lobular BC appears to be distinct from that in nonlobular BC. For risk assessment, the RS needs to be complemented by clinicopathologic parameters for therapy decision making." @default.
• W3048853732 created "2020-08-18" @default.
• W3048853732 creator A5002071285 @default.
• W3048853732 creator A5012681752 @default.
• W3048853732 creator A5014363979 @default.
• W3048853732 creator A5016623639 @default.
• W3048853732 creator A5022444628 @default.
• W3048853732 creator A5023919972 @default.
• W3048853732 creator A5025009422 @default.
• W3048853732 creator A5025263619 @default.
• W3048853732 creator A5027231412 @default.
• W3048853732 creator A5027450608 @default.
• W3048853732 creator A5031666050 @default.
• W3048853732 creator A5040331693 @default.
• W3048853732 creator A5042364191 @default.
• W3048853732 creator A5044665296 @default.
• W3048853732 creator A5049792647 @default.
• W3048853732 creator A5050978422 @default.
• W3048853732 creator A5052512508 @default.
• W3048853732 creator A5054650117 @default.
• W3048853732 creator A5054826844 @default.
• W3048853732 creator A5068847492 @default.
• W3048853732 creator A5045264968 @default.
• W3048853732 date "2020-08-11" @default.
• W3048853732 modified "2023-10-02" @default.
• W3048853732 title "Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer" @default.
• W3048853732 cites W2008511767 @default.
• W3048853732 cites W2012845106 @default.
• W3048853732 cites W2020324632 @default.
• W3048853732 cites W2023057398 @default.
• W3048853732 cites W2039199159 @default.
• W3048853732 cites W2066573281 @default.
• W3048853732 cites W2070170290 @default.
• W3048853732 cites W2078259488 @default.
• W3048853732 cites W2082551530 @default.
• W3048853732 cites W2096910745 @default.
• W3048853732 cites W2105882193 @default.
• W3048853732 cites W2109916911 @default.
• W3048853732 cites W2117228403 @default.
• W3048853732 cites W2125618744 @default.
• W3048853732 cites W2127057139 @default.
• W3048853732 cites W2130900820 @default.
• W3048853732 cites W2131060487 @default.
• W3048853732 cites W2139467064 @default.
• W3048853732 cites W2143858250 @default.
• W3048853732 cites W2144535237 @default.
• W3048853732 cites W2160377567 @default.
• W3048853732 cites W2169100979 @default.
• W3048853732 cites W2289182162 @default.
• W3048853732 cites W2289933199 @default.
• W3048853732 cites W2383449473 @default.
• W3048853732 cites W2409630959 @default.
• W3048853732 cites W2463462735 @default.
• W3048853732 cites W2533893704 @default.
• W3048853732 cites W2614409949 @default.
• W3048853732 cites W2638976208 @default.
• W3048853732 cites W2717601318 @default.
• W3048853732 cites W2728077452 @default.
• W3048853732 cites W2735097279 @default.
• W3048853732 cites W2751066035 @default.
• W3048853732 cites W2805734855 @default.
• W3048853732 cites W2887844673 @default.
• W3048853732 cites W2897778028 @default.
• W3048853732 cites W2898503088 @default.
• W3048853732 cites W2901093859 @default.
• W3048853732 cites W2915774478 @default.
• W3048853732 cites W2948923376 @default.
• W3048853732 cites W2953595023 @default.
• W3048853732 cites W2969551041 @default.
• W3048853732 doi "https://doi.org/10.1002/cncr.33104" @default.
• W3048853732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32780421" @default.
• W3048853732 hasPublicationYear "2020" @default.
• W3048853732 type Work @default.
• W3048853732 sameAs 3048853732 @default.
• W3048853732 citedByCount "30" @default.
• W3048853732 countsByYear W30488537322020 @default.
• W3048853732 countsByYear W30488537322021 @default.
• W3048853732 countsByYear W30488537322022 @default.
• W3048853732 countsByYear W30488537322023 @default.
• W3048853732 crossrefType "journal-article" @default.
• W3048853732 hasAuthorship W3048853732A5002071285 @default.
• W3048853732 hasAuthorship W3048853732A5012681752 @default.
• W3048853732 hasAuthorship W3048853732A5014363979 @default.
• W3048853732 hasAuthorship W3048853732A5016623639 @default.
• W3048853732 hasAuthorship W3048853732A5022444628 @default.
• W3048853732 hasAuthorship W3048853732A5023919972 @default.
• W3048853732 hasAuthorship W3048853732A5025009422 @default.
• W3048853732 hasAuthorship W3048853732A5025263619 @default.
• W3048853732 hasAuthorship W3048853732A5027231412 @default.
• W3048853732 hasAuthorship W3048853732A5027450608 @default.
• W3048853732 hasAuthorship W3048853732A5031666050 @default.
• W3048853732 hasAuthorship W3048853732A5040331693 @default.
• W3048853732 hasAuthorship W3048853732A5042364191 @default.
• W3048853732 hasAuthorship W3048853732A5044665296 @default.
• W3048853732 hasAuthorship W3048853732A5045264968 @default.
• W3048853732 hasAuthorship W3048853732A5049792647 @default.
• W3048853732 hasAuthorship W3048853732A5050978422 @default.
• W3048853732 hasAuthorship W3048853732A5052512508 @default.

• next